Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02701673
Title Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

Burkitt lymphoma

diffuse large B-cell lymphoma

non-Hodgkin lymphoma

Hodgkin's lymphoma

Therapies

Azacitidine

Pyridoxine

Gemcitabine

Belinostat

Busulfan

Melphalan

Age Groups: child | adult
Covered Countries


No variant requirements are available.